Dr. Goodman is Professor of Medicine at Georgetown University, and director of the new Center on Medical Product Access, Safety and Stewardship (COMPASS), which is focused on informing science-based policy to address public health needs. He is Board Certified in Internal Medicine, Infectious Diseases, and Oncology and serves as an infectious diseases consultant at Georgetown University, DC Veterans’ Affairs, and Walter Reed Medical Centers.
Until 2014 he was FDA’s Chief Scientist, leading crosscutting scientific efforts, including public health preparedness and medical countermeasures. Before that, he directed FDA’s Center for Biologics Evaluation and Research (CBER), supporting innovative regulatory approaches to vaccines and other biologics and spearheading unique public-private efforts to address public health challenges such as West Nile Virus, human tissue safety, and influenza vaccine development and availability. As Senior Advisor to the Commissioner, he initiated the first US Task Force on Antimicrobial Resistance (AMR). He helped in developing the Global Vaccine Action Plan and currently serves on WHO’s Ebola Vaccine Advisory Group. Previously, he was Chief of Infectious Diseases at the University of Minnesota.
A Harvard graduate, he received his M.D. from Albert Einstein College of Medicine and completed post-doctoral training at the University of Pennsylvania and UCLA, where he was Chief Resident. He has been elected to the Institute of Medicine of the National Academy of Sciences.